#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IPEX syndrome Marfan's syndrome Endometrial cancer recurrent Prostate cancer Prader-Willi syndrome Lupus nephritis Graft versus host disease Glioblastoma Nephrotic syndrome Phaeochromocytoma Astrocytoma Endometrial cancer Type IIa hyperlipidaemia Metastatic gastric cancer Synovial sarcoma recurrent More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Basic Information Primary immunodeficiency syndrome – Life with Disease Cystic fibrosis lung Fabry’s disease – Trials in Disease Arterial tortuosity syndrome – Basic Information Indolent systemic mastocytosis – Basic Information Rhabdomyosarcoma – Trials in Disease Marginal zone lymphoma refractory – Treatment Leiomyosarcoma – Basic Information Crigler-Najjar syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cendakimab Moxifloxacin Hydrochloride Tocilizumab Acetylsalicylic Acid Ph. Eur. Etifoxine Hydrochloride Lanreotide Inotuzumab Ozogamicin Leniolisib Phosphate Meloxicam Rebisufligene Etisparvovec GSKVX000000034797 Romiplostim Raltegravir Keto-Leucine Calcium Burfiralimab Vinorelbine Pralsetinib Abbv-668 FRUQUINTINIB CLESROVIMAB More therapies…

    Learn about Your Condition

    Tachypnoea Pericarditis Strongyloidiasis Ocular myasthenia Partial lipodystrophy Post-acute COVID-19 syndrome Escherichia infection Prodromal Alzheimer's disease Corneal graft failure B-cell type acute leukaemia Cancer pain Lichenoid keratosis Myeloid leukaemia Gingival bleeding Diabetes mellitus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of EHSG-KF Skin Graft for Patients with Deep Partial and Full-Thickness Burns

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Belgium France Germany Italy The Netherlands Poland +2

  • Study on the Effectiveness of Apixaban for Pain Relief in Patients with Venous Malformations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriovenous malformation
    Investigated Drugs:
    • Apixaban
    Norway

  • Study Comparing ANV419 and High Dose IL2 in Adoptive Cell Therapy for Patients with Melanoma, Non-Small Cell Lung Cancer, and Cervical Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Fusion Protein Of Il-2 And Humanised Igg1 Monoclonal Antibody Against Il-2
    • Anv600
    Denmark The Netherlands Spain

  • Study on the Safety and Efficacy of Cevostamab with Lenalidomide or Iberdomide for Patients with High-Risk or Relapsed Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Cevostamab
    • Iberdomide
    • Lenalidomide
    France Germany Poland Spain

  • Study on Ivermectin for Treating Strongyloidiasis in Adults with Normal Immune Function

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ivermectin
    Spain

  • Study on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Ezetimibe
    • Obicetrapib
    Czechia Hungary Italy The Netherlands Poland Spain
Previous Page
1 … 318 319 320 321 322 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!